Investigation of the Characteristics of Chronic Pain Developing After COVID-19
CompletedNCT04883216
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Data on pain after COVID-19 were generally collected from hospitalized patients and only include information on acute pain conditions. However, the characteristics of the chronic pain experienced after COVID-19 are unknown. For this reason, the treatment and recommendations for patients who present with chronic pain after COVID-19 are not clear. Our goal is to determine the characteristics and risk factors of chronic pain developing in COVID-19 patients and to create specific treatment recommendations for these patient groups with further studies.
Study details
- Official title
- Investigation of the Characteristics of Chronic Pain Developing After COVID-19 in Patients With COVID-19
- Conditions
- Covid19
- Coronavirus
- Chronic Pain
- Sponsor
- Istanbul University
- Start date
- 2021-03-24
- Primary completion
- 2021-12-31
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- Turkey (Türkiye)
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: 1. Being over the age of 18 2. SARS-CoV-2 infection demonstrated with the PCR test (testing date irrelevant) 3. Pain developed or increased after having COVID-19 Exclusion Criteria: 1\. Mental retardation or mental status not eligible to answer the questionnaires
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT04883216